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Fig. 1. Poiseuille´s law, R=ﬂow rate (ml/s), r=radius of the pipe, =dynamic ﬂuid viscosity 
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2. REVIEW OF THE LITERATURE
2.1. AUTONOMIC NERVES
2.1.1. SYMPATHETIC NERVES
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1 G-protein signaling component-adenyl 
cyclase-cAMP-protein kinase A





2 G-protein signaling component-
adenyl cyclase- cAMP-target-speciﬁc 
serine/theorine protein kinase; 
G-protein signaling component 
inhibiting adenyl cyclase; G-protein 
signaling component- phospholipase 
C-diacylglycerol-target-speciﬁc 












3 G-protein signaling component 
inhibiting adenylyl cyclase; G-protein 
signaling components-phospholipase-
C-diacylglycerol-target-speciﬁc 
serine/threonine protein kinase and 
G-protein signaling component-NOS-
NO-guanylyl cyclase- cyclic guanosine 
monophosphate-target-speciﬁc 
serine/threonine protein kinase
Negative on inotropy 
and myocyte survival
_
1A G-protein signaling component 
- phospholipase-C- inositol 
trisphosphate-Ca2++
Positive on heart rate, 
inotropy, and growth in 
myocytes
Vasoconstriction
1B G-protein signaling component 
- phospholipase-C- inositol 
trisphosphate-Ca2++
Positive on heart rate, 
inotropy, and growth in 
myocytes
 _
1D G-protein signaling component 
- phospholipase-C- inositol 
trisphosphate-Ca2++
Contraction of smooth 
muscle cells
Vasoconstriction





2B G-protein signaling component-
inhibiting AC, also G-protein signaling 
component-stimulating adenyl cyclase
Postsynaptically 
counteracts the effects 
of 2 A 
Peripheral 
vasoconstriction
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2.3. ADRENERGIC INNERVATION OF THE VASCULAR WALL
2.3.1. INTRODUCTION
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Figure 2: Schematic representation of adrenergic innervation of the vascular wall. These two 
differ from each other signiﬁcantly. Both ﬁbers leave the spinal column through the posterior 
root. The ﬁbers that are destined to go to the blood vessel leave the spinal column and traverse 
the sympathetic ganglia and enter the spinal nerves that take them to their end organ. Red = 
cholinergic, green = VIPergic, blue = adrenergic ﬁbers (posterior root sensory ﬁbers). Modiﬁed 
























































Fig. 3: Synthesis of noradrenaline (and adrenaline) from their common precursor tyrosine through 
enzymatic steps where tyrosine hydroxylase is the rate-limiting enzyme. Tyrosine hydroxylase 





























































































































































Fig. 4: Nitric oxide (NO) is synthesized by ﬁve-electron oxidation of a guanidino nitrogen of 
L-arginine to yield the gaseous radical (N0) via an N-hydroxyl-L-arginine intermediate. Two 
electrons are donated by NADPH for the formation of this intermediate, plus one electron for 
its oxidation. Both steps are catalyzed by nitric oxide synthase (NOS). Both NO and the ureido 
group of citrulline incorporate molecular oxygen in the process. Sub-stoichiometric amounts 
of tetrahydrobiopterin are also needed with respect to NO generated, if tetrahydrobiopterin 
can be regenerated from its oxidized form, quinonoid dihydrobiopterin. Regeneration of 
tetrahydrobiopterin proceeds through two enzymes, the methotrexate-sensitive enzyme 
dihydrofolate reductase (DHFR) and the methotrexate-resistant enzyme, dihydropteridine 






























































2.4. OTHER NEURONAL ELEMENTS
2.4.1. NEUROFILAMENTS
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2.5 VASCULAR GRAFTS IN A CLINICAL CONTEXT
2.5.1. VENOUS GRAFTS
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3. AIMS OF THE STUDY
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4. MATERIALS AND METHODS
4.1. MATERIALS




































STUDY N Age Weight, g
Follow-up 
time Rats/group
I 9 6 months 330–351 0h, 6h, 24h 3
II 30 3–10 months 220–373
0h, 6h, 12h, 
24h, 48h 6
III 31 2–10 months 254–373
0h, 1w, 4w, 
12w, 20w 5 to 7
IV 12 2–3 months 180–284




















Article  I II III IV
Time
0h x x x x
6h x x    
12h   x    
24h/1d x x   x
48h/2d   x    
72h/3d       x
1w     x x
4w     x x
12w     x x
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4.2.4. HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (II AND III)
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4.2.5. MICROSCOPIC EVALUATION (I AND IV)
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Table 4. Primary antibodies used in Study IV
ANTIBODY SPECIES DILUTION SOURCE REFERENCE
Tyrosine hydroxylase rabbit, pc 1:1000 In collaboration 
with Tong Joh
Vanhatalo 1995
neuronal Nitric Oxide 
Synthase




Endothelial Nitric Oxide 
Synthase





Inducible Nitric Oxide 
Synthase










NEUROFILAMENT mouse, mc 1:10–30 Gift from Prof. 
I. Virtanen
Bäck et al. 1995
mc = monoclonal antibodies
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Fig. 5. Control specimen of an non-operated rat femoral artery wall showing an intact neuronal 



















Table 5. Graft and control weights in milligrams
WEEKS N MEAN ST DEV
CONTR. WEIGHT                  0 6 0.9683 0.1477
1 5
                      
1.1060 0.2281
4 6 1.0967 0.2443
12 6 1.2583 0.1578
20 7 1,1243 0.1875
TOTAL 30 1.1243 0.2039
GRAFT WEIGHT                   0 6 0.9567 0.3028
1 5 2.5620 0.7493
4 6 1.9017 0.4280
12 6 1.7550 0.2843
20 7 1.8829 0.3758
TOTAL 30 1.7890 0.6476
Table 6. Noradrenaline concentrations in the grafts and controls in each experimental animal group 
shown as ng/mg of tissue, and standard deviations
Noradrenaline content of grafts and controls in this material
Mean grafts Mean controls
Group NA ng/mg SD NA ng/mg SD
0h 0,7596 0,1963 1,1105 0,3695
6h 1,5575 1,1115 1,1972 0,518
12h 0,5645 0,1828 1,0113 0,1864
24h 0,1963 0,1556 0,9004 0,3594
48h 0,0293 0,05 0,4982 0,0205
1w 0,0176 0,0152 0,1163 0,2978
4w 0,2797 0,2196 0,1411 0,383
12w 0,3653 0,2796 0,1347 0,3187
































Fig. 6. A graft harvested immediately after operation showing an intact neuronal network



















Fig. 7. A graft six hours after operation showing a diminished amount of glyoxylic acid-induced 


















































Fig. 8. A graft harvested 24 hours after operation showing scant ﬂuorescence with no identiﬁable 






































        
Fig. 9. Tyrosine hydroxylase immunoreactivity 1 (left) and 3 days (right) after the operation, 
showing a clear decrease in the amount of ﬂuorescence (IV). Arrows indicate the white lines of 
tyrosine hydroxylase ﬂuorescence
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eNOS and iNOS ﬁndings
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Fig. 10a. Noradrenaline concentrations (pg/g tissue) for each group of rats. Bars show 
mean values for the graft (Gr) and control (Cntr) groups, with SDs. The rise in noradrenaline 
concentration in grafts at 6h was statistically insigniﬁcant (p>0.05). After 6h the concentration 
in grafts fell signiﬁcantly (p<0.05). In 48-h control specimens the decrease in noradrenaline 
concentration was also statistically signiﬁcant (p=0.04) compared with 0-h controls. 




Fig. 11a. A chart showing noradrenaline concentrations (pg/mg tissue; mean ± SD) in graft 
and control arteries during the postoperative period (weeks). The difference between controls 
and grafts immediately after operation was statistically insigniﬁcant (p=0.053). One week 
postoperatively the difference was statistically signiﬁcant (p<0.001). In the grafts, noradrenaline 
concentrations showed a rising trend from one to 20 weeks (statistically signiﬁcant p=0.004). 
Each group consisted of six rats except for the 20-week group, which consisted of seven rats. 
The data was analyzed by means of Student’s t-test (paired). 
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almost intact little 
diminished
none left











fall in NA 
concentration
signiﬁcant 
fall in NA 
concentration
signiﬁcant 













eNOS intense IR 
against eNOS
iNOS few cells 
present in 
the ta 




GAP-43 rich IR 
throughout ta
less IR than 
in 0-h group
Neuroﬁlament rich IR 
throughout ta
less IR than 
in 0-h group
Table 7. Results of the original articles
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rise in NA 
levels  vs. 1-w 
group
signiﬁcant 
rise in NA 





group in  NA 
concentration
IR  becoming 
sparse
































of cells with 
IR
only a few 
cells present








less IR in ta few ﬁbers to 
be seen
few nerve 





less IR than 
in the 3-m 
group
less IR in ta fewer NF-
staining 
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